Australia TGA ARTG record

Lubricant, eye

Australia TGA ARTG Registered Device · Mentholatum Australasia Pty Ltd · Rohto Pharmaceutical Co Ltd · Class IIa · Started December 16, 2021

Good Name: Mentholatum Australasia Pty Ltd - Lubricant, eye

Device classification

Risk Class: Class IIa
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: December 16, 2021
Effective Date: December 16, 2021

Sponsor

Name: Mentholatum Australasia Pty Ltd

Manufacturer

Name: Rohto Pharmaceutical Co Ltd
Country: Japan
Address: 1-8-1 Tatsumi-Nishi Ikuno-ku, OSAKA, 544-8666

Intended purpose

Temporary relief of dry eye symptoms, including discomfort and low quality of vision due to dry eye, by covering the dry spots and stabilizing the tear film of the eyes.

About this record

Access comprehensive regulatory information for Lubricant, eye in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIa is sponsored by Mentholatum Australasia Pty Ltd, manufactured by Rohto Pharmaceutical Co Ltd in Japan. The device registration started on December 16, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.